Abstract:Owa and Owa inquired about the serologic tests of the 3 neonates and the treatment of neonates with COVID-19.The serologic tests for SARS-CoV-2 were not available until the end of February 2020.Currently, only 6 infected neonates have been reported in China.Four mildly infected neonates improved with primary care.Of 2 critical cases in China, 1 was the third patient in our article, and another neonate with congenital heart disease (6.9-mm atrial septal defect) presented with pneumonia and cardiac insufficiency.The neonate improved rapidly with antibiotics, inotropic therapy, and fluid management.None of the infected neonates received antiviral therapy.Verd et al raised the issue of whether mothers with COVID-19 should continue breastfeeding.Viral nucleic acid for SARS-CoV-2 has not been detected in breast milk thus far.However, the neonates born to an affected mother are at great risk of COVID-19 owing to close contact and should be separated from mothers and fed by formula initially.As our protocol suggested, the isolated mothers should keep pumping to maintain breast milk. 3 Considering the virus may be excreted into the milk during the incubation period, donor milk and breast milk can be considered for use after being screened for SARS-CoV-2. 3 Mimouni et al questioned the criteria used to diagnose COVID-19 pneumonia.In our study, 3 neonates with COVID-19 had not been reported in other cohorts before publication.Patients 1 and 2 were born February 3, 2020, and February 5, 2020, respectively.Patient 1 was admitted to the neonatal intensive care unit owing to lethargy and fever (37.6 °C) at day 3 of life (February 5, 2020).His procalcitonin level (PCT) was 0.090 ng/mL (normal range, ≤0.05 ng/mL).Patient 2 experienced lethargy, vomiting, and fever (37.7 °C), and laboratory test results showed leukocytosis, lymphocytopenia, and an elevated creatine kinase myocardial band.Although no respiratory symptoms were observed and chest images showed infiltrates, the 2 neonates were diagnosed as having symptomatic neonatal COVID-19 based on the exposure history and positive SARS-CoV-2 test result. 3,4 Currently, less than 10 confirmed neonatal cases have been reported.Therefore, the full clinical picture of neonatal COVID-19 remains uncertain.Hijikata et al, Abu Raya et al, and Vecchio pointed out that the serial serologic tests were helpful to diagnose congenital COVID-19.We do agree that viral or serologic test results cannot confirm the intrauterine SARS-CoV-2 infection.However, at the early phase of the COVID-19 epidemic in China, the testing methods for SARS-CoV-2 were limited.Initially, real-time fluorescence PCR was only available for SARS-CoV-2 using nasopharyngeal and oropharyngeal specimens.At present, both serological testing and RT-PCR can be performed; yet, no more neonates with early-onset COVID-19 have been identified with the control of the COVID-19 epidemic in China.We are concerned about the neurologic outcomes of neonates with COVID-19 or born to infected mothers.The study from Zhu et al 5 has shown that 2 newborns presented with elevated PCT levels and interleukin 6 with 72 hours of life (interleukin 6, 274.6 pg/mL and PCT, 9.2 ng/mL in newborn 3; and PCT, 20.74 pg/mL in newborn 4); 1 died of multiple organ failure.These elevated inflammatory markers may be associated with the maternal COVID-19.Therefore, the infants with COVID-19 or born to affected mothers have been followed up in our clinic.

Maternal COVID-19 Infection Associated with Fetal Systemic Inflammatory Complications in COVID-19-Negative Neonates: A Case-Series

Maternal and neonatal outcomes associated with illness severity of maternal COVID-19

Clinical features of neonates born to mothers with coronavirus disease-2019: A systematic review of 105 neonates

#49: Management and Outcomes of Infants Born to Mothers with SARS-CoV-2 Infection in Pregnancy

Maternal-Fetal Characteristics of Pregnant Women With Severe COVID Disease and Maternal-Neonatal Characteristics of Neonates With Early-Onset SARS-CoV-2 Infection: A Prospective Data Analysis

Neonatal outcomes of maternal prenatal coronavirus infection

Intrauterine activation of the fetal immune system in response to maternal COVID-19

Neonatal outcomes and indirect consequences following maternal SARS-CoV-2 infection in pregnancy: a systematic review

Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2

Analysis of Maternal Coronavirus Infections and Neonates Born to Mothers with 2019-nCoV; a Systematic Review

Neonatal severe COVID-19 infection complicated by Staphilococcus aureus could be misinterpreted as MIS-C?: case report and review of literature

Clinical Analysis of Neonates Born to Mothers with or without COVID-19: A Retrospective Analysis of 48 Cases from Two Neonatal Intensive Care Units in Hubei Province

Maternal and Neonatal Outcomes During the COVID-19 Infection in China: Data from a Retrospective Cohort Study

Neuroimaging assessment of pediatric cerebral changes associated with SARS-CoV-2 infection during pregnancy

Association of maternal infection of SARS-CoV-2 and neonatal susceptibility: A retrospective cohort study

Neonatal Outcome in 29 Pregnant Women with COVID-19: A Retrospective Study in Wuhan, China

Error in the Abstract and Results Section

Maternal and neonatal outcomes in pregnant women with COVID-19: a systemic review

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection

Placental pathology in SARS-CoV-2 infected pregnancies: A single-institution retrospective cohort analysis

Multisystem Inflammatory Syndrome in a Newborn (MIS-N): Clinical Evidence and Neurodevelopmental Outcome